Default: Journal of Alzheimer's Disease

ISSN: 1387-2877

Journal Home

Journal Guideline

Journal of Alzheimer's Disease Q1 Unclaimed

IOS Press Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Alzheimer's Disease is a journal indexed in SJR in Medicine (miscellaneous) and Neuroscience (miscellaneous) with an H index of 127. It has an SJR impact factor of 1,586 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

Journal of Alzheimer's Disease

1,586

SJR Impact factor

127

H Index

729

Total Docs (Last Year)

2184

Total Docs (3 years)

40390

Total Refs

8784

Total Cites (3 years)

2149

Citable Docs (3 years)

4,04

Cites/Doc (2 years)

55,4

Ref/Doc


Best articles

A Natural Benzofuran from the Patagonic Aleurodiscus vitellinus Fungus has Potent Neuroprotective Properties on a Cellular Model of Amyloid-beta Peptide Toxicity

View more

A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment

View more

ABCA7 Genotype Moderates the Effect of Aerobic Exercise Intervention on Generalization of Prior Learning in Healthy Older African Americans

View more

Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin

View more

Adiposity, Weight Change, and Risk of Cognitive Impairment: The Singapore Chinese Health Study

View more

Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease

View more

Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

View more

Amyloid-beta/Drug Interactions from Computer Simulations and Cell-Based Assays

View more

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease

View more

Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations

View more

Association between a-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI

View more

Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People

View more
SHOW MORE ARTICLES

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

View more

Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease

View more

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

View more

Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers

View more

Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden

View more

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study

View more

Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging

View more

Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy

View more

Dietary Lactoferrin Supplementation Prevents Memory Impairment and Reduces Amyloid-beta Generation in J20 Mice

View more

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease

View more

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

View more

Effect of APOE e4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease

View more

Comments

No comments ... Be the first to comment!